Neurobiology of Diabetic Neuropathy
- David Tomlinson, University of Manchester, United Kingdom
- Ronald Bradley, Louisiana State University Medical Center, School of Medicine, Baton Rouge, U.S.A.
- R. Harris, University of Texas, Austin, USA
- Peter Jenner, King's College, London, U.K. Head of Pharmacology and Therapeutics Division
This volume of International Review of Neurobiology defines primary biochemical causation of diabetic complications, identifies cellular glucose transducers, balancing roles of protein kinase C and MAP kinases, and sets in context the role of apoptosis and the interactive roles of neurons and Schwann cells. It also defines the cell biology of autonomic neuropathy, considers the balanced needs of science, clinical practice, and economics in clinical trial design, provides the definitive evaluation of aldose reductase inhibitors, and explains the failure of nerve growth factor.
Neurologists, pediatric neurologists, epileptologists, developmental neuroscientists, medical geneticists, and developmental biologists.